Women's Hospital HUS Report issue

Academic/Hospital Phase 4
Founded: Helsinki Finland

Organization Overview

First Clinical Trial
2021
NCT04645823
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

HUCH, Women's hospital/dept of anesthesia | Women's Hospital HUS

Active Ingredients

Drugs in Phase 4 Trials (2)

fentanyl (Innovar) (1 trial)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Labor Pain (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2